Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Approaches for Market Estimation
1.3.1 Approach 1: Demand analysis & bottom-up approach
1.3.2 Approach 2: Top-down market estimation
1.3.3 Approach 3: Commodity flow and bottom-up market estimation
1.3.4 Approach 4: KoL perspective-based market sizing

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Pancreatic Cancer Treatment Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.2 Market restraint analysis
3.3 Key Opportunities Prioritized
3.4 Industry Analysis Porter’s
3.5 PESTEL Analysis

Chapter 4 Pancreatic Cancer Treatment Market: Affected Region Estimates & Trend Analysis
4.1 Pancreatic Cancer Treatment Market: Affected Region Movement Analysis
4.2 Exocrine
4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
4.3 Endocrine
4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Pancreatic Cancer Treatment Market: Treatment Estimates & Trend Analysis
5.1 Pancreatic Cancer Treatment Market: Treatment Movement Analysis
5.2 Chemotherapy
5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.3 Targeted Therapy
5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.4 Others
5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6 Pancreatic Cancer Treatment Market: Regional Estimates & Trend Analysis, by Affected region & Application
6.1 Pancreatic Cancer Treatment Market Share by Region, 2015 & 2025
6.2 North America
6.2.1 U.S.
6.2.1.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.2.1.2 Market estimates and forecasts, by application, 2014 - 2025
6.2.2 Canada
6.2.2.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.2.2.2 Market estimates and forecasts, by application, 2014 - 2025
6.3 Europe
6.3.1 U.K.
6.3.1.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.3.1.2 Market estimates and forecasts, by application, 2014 - 2025
6.3.2 Germany
6.3.2.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.3.2.2 Market estimates and forecasts, by application, 2014 - 2025
6.4 Asia Pacific
6.4.1 China
6.4.1.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.4.1.2 Market estimates and forecasts, by application, 2014 - 2025
6.4.2 Japan
6.4.2.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.4.2.2 Market estimates and forecasts, by application, 2014 - 2025
6.5 Latin America
6.5.1 Brazil
6.5.1.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.5.1.2 Market estimates and forecasts, by application, 2014 - 2025
6.5.2 Mexico
6.5.2.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.5.2.2 Market estimates and forecasts, by application, 2014 - 2025
6.6 MEA
6.6.1 South Africa
6.6.1.1 Market estimates and forecasts, by affected region, 2014 - 2025
6.6.1.2 Market estimates and forecasts, by application, 2014 - 2025

Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Company Profiles
7.2.1 Eli Lily and Company
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Celgene Corporation
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Hoffmann-La Roche AG
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Amgen, Inc.
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Novartis AG
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 PharmaCyte Biotech, Inc.
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Clovis Oncology
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
7.2.8 Teva Pharmaceutical Industries Ltd.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.4 Strategic initiatives
7.2.9 Merck & Co., Inc.
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Product benchmarking
7.2.9.4 Strategic initiatives
7.2.10 Pfizer, Inc.
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Product benchmarking
7.2.10.4 Strategic initiatives

List of Tables
TABLE 1 Pancreatic cancer treatment market - Industry snapshot
TABLE 2 Pancreatic cancer treatment market, by affected region, 2014 - 2025 (USD Million)
TABLE 3 Pancreatic cancer treatment market, by treatment, 2014 - 2025 (USD Million)
TABLE 4 Pancreatic cancer treatment market, by region, 2014 - 2025 (USD Million)
TABLE 5 Pancreatic cancer treatment market - Key market driver analysis
TABLE 6 Pancreatic cancer treatment market - Key market restraint analysis
TABLE 7 North America market, by affected region, 2014 - 2025 (USD Million)
TABLE 8 North America market, by treatment, 2014 - 2025 (USD Million)
TABLE 9 U.S. market, by affected region, 2014 - 2025 (USD Million)
TABLE 10 U.S. market, by treatment, 2014 - 2025 (USD Million)
TABLE 11 Canada market, by affected region, 2014 - 2025 (USD Million)
TABLE 12 Canada market, by treatment, 2014 - 2025 (USD Million)
TABLE 13 Europe market, by affected region, 2014 - 2025 (USD Million)
TABLE 14 Europe market, by treatment, 2014 - 2025 (USD Million)
TABLE 15 UK market, by affected region, 2014 - 2025 (USD Million)
TABLE 16 UK market, by treatment, 2014 - 2025 (USD Million)
TABLE 17 Germany market, by affected region, 2014 - 2025 (USD Million)
TABLE 18 Germany market, by treatment, 2014 - 2025 (USD Million)
TABLE 19 Asia Pacific market, by affected region, 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific market, by treatment, 2014 - 2025 (USD Million)
TABLE 21 Japan market, by affected region, 2014 - 2025 (USD Million)
TABLE 22 Japan market, by treatment, 2014 - 2025 (USD Million)
TABLE 23 China market, by affected region, 2014 - 2025 (USD Million)
TABLE 24 China market, by treatment, 2014 - 2025 (USD Million)
TABLE 25 Latin America market, by affected region, 2014 - 2025 (USD Million)
TABLE 26 Latin America market, by treatment, 2014 - 2025 (USD Million)
TABLE 27 Brazil market, by affected region, 2014 - 2025 (USD Million)
TABLE 28 Brazil market, by treatment, 2014 - 2025 (USD Million)
TABLE 29 Mexico market, by affected region, 2014 - 2025 (USD Million)
TABLE 30 Mexico market, by treatment, 2014 - 2025 (USD Million)
TABLE 31 MEA market, by affected region, 2014 - 2025 (USD Million)
TABLE 32 MEA market, by treatment, 2014 - 2025 (USD Million)
TABLE 33 South Africa market, by affected region, 2014 - 2025 (USD Million)
TABLE 34 South Africa market, by treatment, 2014 - 2025 (USD Million)

List of Figures
FIG. 1 Global pancreatic cancer treatment: Market segmentation
FIG. 2 Global pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 3 Pancreatic cancer treatment: Market dynamics
FIG. 4 Pancreatic cancer treatment market: Porter’s analysis
FIG. 5 Key opportunities prioritized
FIG. 6 Pancreatic cancer treatment market: PESTEL analysis
FIG. 7 Pancreatic cancer treatment market share, by affected region, 2015 & 2025
FIG. 8 Exocrine market, 2014 - 2025 (USD Million)
FIG. 9 Endocrine market, 2014 - 2025 (USD Million)
FIG. 10 Pancreatic cancer treatment market share, by type, 2015 & 2024
FIG. 11 Chemotherapy market, 2014 - 2025 (USD Million)
FIG. 12 Targeted therapy market, 2014 - 2025 (USD Million)
FIG. 13 Others market, 2014 - 2025 (USD Million)
FIG. 14 Pancreatic cancer treatment market share, by region, 2015 & 2025
FIG. 15 North America pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 16 U.S. pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 17 Canada pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 18 Europe pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 19 UK pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 20 Germany pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 21 Asia Pacific pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 22 Japan pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 23 China pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 24 Latin America pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 25 Brazil pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 26 Mexico pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 27 MEA pancreatic cancer treatment market, 2014 - 2025 (USD Million)
FIG. 28 South Africa pancreatic cancer treatment market, 2014 - 2025 (USD Million)